BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu B, Zhang Q, Zhang P, Hu X, Li W, Tong Z, Sun T, Teng Y, Wu X, Ouyang Q, Yan X, Cheng J, Liu Q, Feng J, Wang X, Yin Y, Shi Y, Pan Y, Wang Y, Xie W, Yan M, Liu Y, Yan P, Wu F, Zhu X, Zou J; DAWNA-1 Study Consortium. Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial. Nat Med 2021;27:1904-9. [PMID: 34737452 DOI: 10.1038/s41591-021-01562-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Meng Y, Wang B, Wang L, Cao J, Tao Z, Li T, Yao W, Hu X. Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study. Front Oncol 2022;12:775081. [DOI: 10.3389/fonc.2022.775081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Perez-Garcia JM, Cortes J, Llombart-Cussac A. CDK4/6 inhibitors in breast cancer: spotting the difference. Nat Med 2021;27:1868-9. [PMID: 34750558 DOI: 10.1038/s41591-021-01570-9] [Reference Citation Analysis]
3 Couckuyt A, Seurinck R, Emmaneel A, Quintelier K, Novak D, Van Gassen S, Saeys Y. Challenges in translational machine learning. Hum Genet 2022. [PMID: 35246744 DOI: 10.1007/s00439-022-02439-8] [Reference Citation Analysis]
4 Giannoccaro MP, Vacchiano V, Leone M, Camilli F, Zenesini C, Panzera I, Balboni A, Tappatà M, Borghi A, Salvi F, Lugaresi A, Rinaldi R, Di Felice G, Lodi V, Lazzarotto T, Liguori R; ANCOVAX study group. Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study. J Neurol 2022. [PMID: 35503375 DOI: 10.1007/s00415-022-11142-7] [Reference Citation Analysis]
5 Rodriguez-Cuenca S, Vidal-Puig A. Insulin and the last gasp of failing adipocytes. Nat Metab 2021;3:1443-4. [PMID: 34732886 DOI: 10.1038/s42255-021-00492-7] [Reference Citation Analysis]
6 Redecke V, Tawaratsumida K, Larragoite ET, Williams ESCP, Planelles V, Spivak AM, Hirayama L, Elgort M, Swenson S, Smith R, Worthen B, Zimmerman R, Slev P, Cahoon B, Astill M, Häcker H. A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation. Sci Rep 2021;11:24507. [PMID: 34969960 DOI: 10.1038/s41598-021-04298-1] [Reference Citation Analysis]
7 Meyer M, Constancias F, Worth C, Meyer A, Muller M, Boussuge A, Kaltenbach G, Schmitt E, Chayer S, Velay A, Vogel T, Fafi-Kremer S, Karcher P. Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds. Geroscience 2022. [PMID: 35394604 DOI: 10.1007/s11357-022-00546-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]